Intramuscular Vitamin D in Pregnancy
Oral vitamin D supplementation is preferred over intramuscular administration during pregnancy, with empiric daily supplementation of approximately 2500 IU recommended to reduce risks of pre-eclampsia, preterm birth, and neonatal mortality. 1
Route of Administration
The 2024 Endocrine Society guidelines explicitly recommend daily, lower-dose vitamin D over non-daily, higher doses for empiric supplementation during pregnancy 1. While the FDA label for intramuscular vitamin D exists 2, and animal studies show no reproductive toxicity with IM administration 3, the guideline evidence base derives from trials using oral supplementation. The FDA label cautions that vitamin D in excess of 400 IU daily during pregnancy has not been established as safe, though this reflects older conservative guidance 2.
Recommended Dosing Strategy
For empiric supplementation during pregnancy, use 2500 IU (63 μg) daily via oral route 1. This represents the weighted average dose from clinical trials showing benefits for:
- Pre-eclampsia risk reduction
- Lower intra-uterine mortality
- Decreased preterm birth rates
- Reduced small-for-gestational-age births
- Lower neonatal mortality
The trials supporting these outcomes used dosages ranging from 600-5000 IU daily equivalent, typically given daily or weekly 1.
Testing Considerations
Do not perform routine 25(OH)D testing in healthy pregnant women 1. The guideline explicitly recommends against:
- Screening to guide supplementation decisions
- Follow-up testing to adjust vitamin D dosing
This applies to generally healthy pregnant individuals without established indications like hypocalcemia 1.
Evidence Quality and Caveats
The Cochrane review (2024) found that after removing studies with trustworthiness concerns, the evidence became low to very low certainty 4. However, the Endocrine Society guideline rates their pregnancy recommendation as moderate certainty (⊕⊕◯◯) 1. Recent research confirms that 1000 IU daily supplementation is insufficient - 67% of deficient women remained deficient on this dose 5, supporting the higher 2500 IU recommendation.
Critical pitfall: The French GRIO position acknowledges that recommended intakes vary widely internationally from 400-4000 IU 6. The narrow therapeutic window mentioned in the FDA label 2 primarily applies to treatment of vitamin D-resistant rickets, not routine pregnancy supplementation.
Practical Implementation
Empiric vitamin D may be delivered through:
- Daily oral supplements (preferred)
- Prenatal vitamin formulations containing vitamin D
- Fortified foods
Avoid intramuscular bolus dosing as the evidence base and current guidelines favor daily oral administration for safety and efficacy 1.